5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.

Source:http://linkedlifedata.com/resource/pubmed/id/8863819

Download in:

View as

General Info

PMID
8863819